yep, memory serves you right kbear1 - a 9 month wait
analysts some time ago placed a $1.20 target with today's FDA approval -- thing with ACL is that the revenues from their generic drug will be used to develop a new cancer drug they have been working on, so now they will be fully funded to complete their development
but your right also - ACL is getting into an established market with this generic
we, on the otherhand, are aiming for a new space unoccupied by any close competitor -- plus all the murmurs of branching off into other cancer therapies -- a much more lucrative horizon than ACL, should we/PRR prove successful on CVac AND the other cancer fronts
fingers crossed as usual
good luck
wednesday... navel gazing, page-15
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |